Bahl & Gaynor’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-14,948
| Closed | -$405K | – | 408 |
|
|
2016
Q1 | $405K | Buy |
14,948
+614
| +4% | +$16.6K | 0.01% | 331 |
|
|
2015
Q4 | $416K | Sell |
14,334
-10,320
| -42% | -$300K | 0.01% | 336 |
|
|
2015
Q3 | $669K | Buy |
24,654
+194
| +0.8% | +$5.26K | 0.01% | 276 |
|
|
2015
Q2 | $670K | Sell |
24,460
-500
| -2% | -$13.7K | 0.01% | 287 |
|
|
2015
Q1 | $666K | Hold |
24,960
| – | – | 0.01% | 273 |
|
|
2014
Q4 | $528K | Sell |
24,960
-200
| -0.8% | -$4.23K | 0.01% | 287 |
|
|
2014
Q3 | $599K | Sell |
25,160
-1,600
| -6% | -$38.1K | 0.01% | 263 |
|
|
2014
Q2 | $618K | Hold |
26,760
| – | – | 0.01% | 252 |
|
|
2014
Q1 | $611K | Sell |
26,760
-1,840
| -6% | -$42K | 0.01% | 250 |
|
|
2013
Q4 | $528K | Sell |
28,600
-300
| -1% | -$5.54K | 0.01% | 259 |
|
|
2013
Q3 | $489K | Hold |
28,900
| – | – | 0.01% | 249 |
|
|
2013
Q2 | $448K | Buy |
+28,900
| New | +$448K | 0.01% | 244 |
|